Analyst Ratings for Amylin Pharmaceuticals (AMLN)

AMLN Rating Summary

  |   Expand Research on AMLN
Overall Rating: NEUTRAL   Rating Trend: =   Avg. $ Target: N/A
Date Firm Type Rating
(Past)
PT
(Past)
Start $ End $ % Chg. Details
7/3/2012 Morgan Stanley Upgrade Equalweight
(Underweight)
N/A
(N/A)
30.71 30.98 0.88% Details
7/2/2012 BMO Capital Downgrade Market Perform
(Outperform)
N/A
(N/A)
28.20 30.98 9.86% Details
Like AMLN Ratings? Also take a look at

AMLN Ratings News